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Abstract 25 
Protein aggregation and abnormal lipid homeostasis are both implicated in neurodegeneration through 26 
unknown mechanisms. Here we demonstrate that aggregate-membrane interaction is critical to induce a 27 
form of cell death called ferroptosis. Importantly the aggregate-membrane interaction that drives 28 
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ferroptosis depends both on the conformational structure of the aggregate, as well as the oxidation state of 1 
the lipid membrane. We generated human stem cell derived models of synucleinopathy, characterised by 2 
the intracellular formation of g-synuclein aggregates that bind to membranes. In human iPSC derived 3 
neurons with SNCA triplication, physiological concentrations of glutamate and dopamine induce 4 
abnormal calcium signalling due to the incorporation of excess g-synuclein oligomers into membranes, 5 
leading to altered membrane conductance and abnormal calcium influx. g-synuclein oligomers further 6 
induce lipid peroxidation. Targeted inhibition of lipid peroxidation prevents the aggregate-membrane 7 
interaction, abolishes aberrant calcium fluxes, and restores physiological calcium signalling. Inhibition of 8 
lipid peroxidation, and reduction of iron dependent accumulation of free radicals, further prevents 9 
oligomer induced toxicity in human neurons. In summary, we report that peroxidation of polyunsaturated 10 
fatty acids underlies the incorporation of く-sheet rich aggregates into the membranes, and that 11 
additionally induces neuronal death. This suggests a role for ferroptosis in Parkinsons disease, and 12 
highlights a new mechanism by which lipid peroxidation causes cell death. 13 
 14 
Introduction  15 
Synucleinopathies are neurodegenerative diseases that are characterised by the abnormal aggregation of 16 
the protein g-synuclein, and include Dementia with Lewy Body Disease, Parkinsons Disease (PD) and 17 
Multiple System Atrophy (MSA) (1). Within this group of diseases, it is evident that g-synuclein 18 
aggregation, or Lewy Body pathology, occurs in diverse cell groups including the enteric nervous system, 19 
midbrain dopaminergic neurons, and cortical neurons (2-5). Genetic evidence shows that alteration in the 20 
concentration or structure of g-synuclein causes the synucleinopathies, in particular PD. Missense 21 
mutations, and duplications or triplications of the SNCA gene, lead to autosomal dominant PD (6-9) that 22 
is indistinguishable from sporadic PD, apart from early onset and a more aggressive course. Variations in 23 
the SNCA gene that lead to increased g-synuclein expression represent a genetic risk factor for sporadic 24 
PD (10).  25 
Compelling pathological and genetic data defines g-synuclein as the cause of synucleinopathies, and 26 
raises the question of how aggregation induces cellular dysfunction and death. During aggregation, g-27 
synuclein transitions from an intrinsically disordered monomeric protein to form small soluble oligomers 28 
with increasing く- sheet content, followed by protofibrils and insoluble fibrils. The soluble intermediate 29 
oligomeric species of g-synuclein may be ‘toxic’ to cells, and the toxicity of certain oligomers of g-30 
synuclein may be attributed to specific structural characteristics that confer damaging properties (11). It is 31 
well established that g-synuclein interacts with lipids in its monomeric form, where it may regulate 32 
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synaptic vesicle trafficking (12). Importantly, oligomers of high く-sheet content and exposed hydrophobic 1 
residues also interact with lipids, and disrupt or damage membrane structure, resulting in aberrant ion 2 
fluxes (13-15). We have also demonstrated that oligomeric species can generate reactive oxygen species 3 
within the cell, and this leads to the oxidation of lipids in the plasmalemmal and mitochondrial 4 
membranes, as well as oxidation of mitochondrial proteins (13, 16, 17). Oligomer induced oxidation 5 
events open the mitochondrial permeability transition pore, leading to apoptosis (18). However, other 6 
forms of cell death also exist, and death by ferroptosis has emerged to describe cell toxicity driven by 7 
the iron dependent accumulation of lipid peroxides (19).  8 
In this study, we utilized two human stem cell derived models of synucleinopathy to investigate how 9 
protein aggregation, calcium signalling, and redox biology interact to induce toxicity. We investigate (i) 10 
the effect of cellular uptake of exogenously applied recombinant oligomers, in which we can control the 11 
structure and concentration of the species and (ii) the effect of longer term endogenous increased 12 
expression of g-synuclein from SNCA mutations, and therefore the consequence of endogenously 13 
generated oligomeric species. g-synuclein aggregation occurs in human neurons, and these aggregates 14 
deregulate physiological calcium signalling, an effect dependent on the interaction between aggregates 15 
and membranes. Importantly modulation of the oxidation state of the lipids changes the membrane - g-16 
synuclein interactions, and cell viability, highlighting the cell death pathway, ferroptosis, in these models. 17 
 18 
Material and Methods 19 
Human stem cell derived models 20 
Human Induced Pluripotent Stem Cell (iPSC) culture 21 
iPSCs were derived from donors who had given signed informed consent for derivation of iPSC lines 22 
from skin biopsies as part of the EU IMI-funded programme StemBANCC. All experimental protocols 23 
had approval from the London - Hampstead Research Ethics Committee (ref: 13/LO/0171, IRAS project 24 
ID: 100318) and R&D approval from the University College London Great Ormond Street Institute of 25 
Child Health and Great Ormond Street Hospital Join Research Office.  26 
iPSC-derived cortical neurons from 3 SNCA triplication (SNCA x3) clones and 3 control clones were 27 
generated using standard protocols, and all experiments were performed on a minimum of 3 independent 28 
inductions. Experiments were repeated using the SNCA x3 clones, and an isogenic clone generated from 29 
the same patient.  iPSCs were generated from a patient with early onset autosomal dominant PD due to a 30 
triplication of the SNCA gene (encoding g-synuclein) using viral transduction of OCT4, SOX2, KLF4 31 
and c-MYC (20). SNCA x3 results in four copies of the SNCA gene, and a doubling of SNCA mRNA 32 
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and g-synuclein protein. CRISPR/Cas 9 nickase technology was employed to remove 2 SNCA alleles to 1 
restore the SNCA gene dosage to 2 copies, whilst retaining the rest of the triplication locus (that is, the 2 
isogenic control, (21). The isogenic cell line was generated from a SNCA x3 iPSC clone by CRISPR/Cas9 3 
double nickase gene editing to knockout 2 SNCA alleles, reducing the allele dosage from 4 (in the 4 
triplication cells) to 2 (normal). This method retains the rest of the triplication locus intact, and therefore 5 
provides the ideal control for the effects of SNCA x3 alone.  6 
iPSCs were cultured on Geltrex (Thermo-Fisher) in Essential 8 medium (Thermo-Fisher) and passaged 7 
using 0.5 mM EDTA (Thermo-Fisher). Neural induction was performed through dual SMAD inhibition 8 
using SB431542 (10 µM, Tocris) and Dorsomorphin dihydrochloride (1 µM Tocris) within N2B27 media 9 
- DMEM;F12+ glutamax, Neurobasal, B28, N2, Glutamax, Insulin, Non Essential Amino Acids, 2-10 
mercaptoethanol, Pen/strep- (modified from (22). Cells were first passaged with Dispase (Thermo-Fisher, 11 
1:2) at day 10 upon first appearance of the neuroepithelial sheet. Upon appearance of neural rosettes at 12 
day 20 - 21, cells are passaged again with Dispase. Cells were passaged approximately 3 more times 13 
before being used at day 70 - 90. All lines were mycoplasma tested (all negative) and performed with 14 
STR profiling (all matched) by the Francis Crick Institute Cell service team.  15 
Human Embryonic Stem cells (ES) culture  16 
The hESC line was kindly provided by Dr. David Hay (University of Edinburgh), upon MRC Steering 17 
Committee approval (ref. no. SCSC11-60). The line was established at the Centre for Stem Cell Biology 18 
(University of Sheffield) under a license from the Human Fertilisation and Embryology Authority, and 19 
has been validated to show the standard hESC characteristics including a normal karyotype. Briefly, 20 
pCAG-SNCA-IRES-Venus or the control pCAG-IV were transfected into hES cells followed by 21 
antibiotic selection to allow the generation of clones with stable expression of SNCA. Clones exhibiting 22 
normal morphology, growth and differentiation behaviour were selected and characterised for SNCA 23 
expression, and two clones with near normal levels of SNCA expression (here designated control) and 24 
high levels of SNCA expression (designated as hES OE syn) were utilized for further studies. 25 
For neural induction, hES cells were dissociated into single cells with Accutase (Gibco, Cat. no. A11105-26 
01) and plated on a Matrigel-coated 6-well plate in mTeSR1 medium. Cells were fed daily until they 27 
reached 90% confluency or above. Neural induction started at day 0, when mTeSR1 was replaced with 28 
hESC medium lacking FGF2, supplemented with 10 たM SB431542 (Tocris) and 100 nM LDN-193189 29 
(Stemgent). Cells were fed daily with this medium until day 4. From day 5 to day 11, SB431542 was 30 
withdrawn and cells were fed every other day with a mixture of hESC medium and N2B27, which was 31 
gradually added into culture medium from 25%, 50%, 75% and 100% at day 5, day 7, day 9 and day 11, 32 
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respectively. pCAG-SNCA-IRES-Venus or the control pCAG-IV were transfected into hES cells 1 
followed by antibiotic selection to allow the generation of clones with stable expression of SNCA. Clones 2 
exhibiting normal morphology, growth and differentiation behaviour were selected and characterised for 3 
SNCA expression, and two clones with near normal levels of SNCA expression (here designated control) 4 
and high levels of SNCA expression (designated as hES OE syn) were utilized for further studies. 5 
 6 
Aggregation of g-synuclein 7 
Wild-type g-synuclein and A90C variant were purified from Escherichia coli. as previously described by 8 
Hoyer et al (23). All gS aggregations (using labelled or unlabelled protein) were conducted in LoBind 9 
microcentrifuge tubes (Eppendorf) to limit surface adsorption. 10 
For the aggregation reactions of unlabeled recombinant g-synuclein, a 70 たM solution of wild-type g-11 
synuclein in 25 mM Tris buffer with 100 mM NaCl pH 7.4 (supplemented with 0.01% NaN3 to prevent 12 
bacterial growth during aggregation) was incubated at 37°C with constant agitation at 200rpm (New 13 
Brunswick Scientific Innova 43), during which time aliquots were taken.  14 
For the aggregation reactions of labelled g-synuclein, the A90C variant of monomeric gS was labeled 15 
with maleimide-linked Alexa Fluor 488 (AF488) or Alexa Fluor 594 (AF594) (Life Technologies) as 16 
described previously (16, 24). The excess dye was removed by passing the labeled protein through a P10 17 
desalting column containing Sephadex G25 matrix (GE Healthcare, Waukesha, WI). After elution, protein 18 
concentration was determined using a nanodrop and the sample divided into aliquots, before being flash-19 
frozen in liquid nitrogen and stored at −80 °C. Each aliquot was only thawed once prior to use. AF488-20 
labelled and AF594-labelled monomeric gS were diluted in Tris buffer (same composition as mentioned 21 
above) at a concentration of 70 µM. For FRET experiments, AF488-labelled and AF594-labelled 22 
monomeric gS were incubated together to a final concentration of 70 µM. Similar to the aggregation of 23 
unlabeled gS, the reaction was performed in the dark at 37 °C with constant agitation at 200 rpm (same 24 
incubator as above) and aliquots were withdrawn at specific time points.  25 
Different time points of unlabelled g-synuclein aggregation reaction were characterized using a highly 26 
sensitive single-molecule method termed SAVE (Single Aggregate Visualisation by Enhancement) 27 
imaging, which uses single-molecule fluorescence microscopy to detect the benzothiazole salt thioflavin-28 
T (ThT) see Sup Fig 1. Upon binding to く-sheet structures, ThT fluorescence increases allowing 29 
individual aggregated species to be detected. From 2 h onwards, the number of diffraction limited 30 
fluorescent puncta increases, which represents the emergence of oligomers and at later time points (> 24 31 
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h), fibrils as long as 5 µm are observed. For this study, we used time point 0h (no aggregates), 8h 1 
(maximum number of oligomers without the presence of fibrils) and 24 h (16)(fibrils). The kinetics of 2 
labelled g-synuclein reaction is different from the unlabelled and the time point that maximizes the 3 
number of oligomers is around 29h and fibrils appear after 72h. 4 
 5 
Deuteration of PUFAs 6 
Deuteration of PUFAs, Deuterated Poly-Unsaturated Fatty Acids (D-PUFAs) were prepared as described 7 
previously (25) and used as free acids. Non-deuterated PUFAs were obtained from SigmaAldrich (99%; 8 
St. Louis, MO, USA). Cells were pre-incubated with 10 ʅM D-PUFA in the culturing media for 48 hrs 9 
prior to experiment and washed with HBSS before experiments. 10 
 11 
Live Imaging (Fluorescence Measurements) 12 
Fluorescent indicators (fura-2 AM, Dihydroethidium, C11-BODIPY, SYTOX Green) were used to 13 
measure [Ca2+], reactive oxygen species (ROS), and lipid peroxidation, and cell death respectively. The 14 
fluorescent data was collected using a cooled camera device or a confocal microscope.  For fluorescence 15 
measurements with cooled camera device, data were obtained on an epifluorescence inverted microscope 16 
equipped with a x 20 fluorite objective. For confocal microscopy, images were obtained using an either 17 
Zeiss 710 or 880 (airy) vis CLSM equipped with a META detection system and a 40x oil immersion 18 
objective. Illumination intensity was kept to a minimum (at 0.1 - 0.2 % of laser output) to avoid 19 
phototoxicity and the pinhole set to give an optical slice of ~2 µm. All data presented were obtained from 20 
at least 3 coverslips and 2 - 3 different induction.  21 
For measurements of [Ca2+]c, cells were loaded for 30 min at room temperature with 5 µM Fura-2 AM 22 
with 0.005% pluronic acid in a HEPES-buffered salt solution (HBSS) composed of (mM): 156 NaCl, 3 23 
KCl, 2MgSO4, 1.25 KH2PO4, 2 CaCl2, 10 Glucose and 10 HEPES; pH adjusted to 7.35 with NaOH. 24 
[Ca2+]c was monitored in single cells using excitation light provided by a Xenon arc lamp, the beam 25 
passing through monochromator centred sequentially at 340 and 380 nm (Cairn Research, Kent, UK).  26 
Emitted fluorescence light was reflected through a 515 nm long-pass filter to a cooled CCD camera 27 
(Retiga, QImaging, Canada). All imaging data was collected and analysed using software from Andor 28 
(Belfast, UK). The Fura2 data have not been calibrated in terms of [Ca2+]c because of the uncertainty 29 
arising from the use of different calibration techniques. For Dihydroethidium (Het) we generated ratios of 30 
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the oxidised form (ethidium) excited at 530 nm and measured using a 560 nm longpass filter and the 1 
reduced form with excitation at 380 nm, measured between 415 - 470nm.  2 
To assess lipid peroxidation, cells were loaded with C11-BODIPY (581/591, 2 たM, Molecular Probes) in 3 
HEPES buffered HBSS for 20 min prior to imaging and then excited using the 488 and 565 nm laser and 4 
fluorescence measured from 505 to 550 nm and above 580 nm (409 objective) using a confocal 5 
microscopy. The intensely fluorescent C11-BODIPY 581/591 fluorophore is an intrinsically lipophilic 6 
dye which results in accumulation within membranes. Upon oxidation of the polyunsaturated butadienyl 7 
portion of the dye, there is a shift of the fluorescent emission peak from 590 nm to 510 nm, and it remains 8 
lipophilic, thus reflecting lipid peroxidation in membranes.  9 
For SYTOX green (Molecular Probes), cells were loaded with SYTOX green in HEPES buffered HBSS 10 
for 15 min. High-throughput images were acquired using an Opera Phenix High-Content Screening 11 
System (PerkinElmer). SYTOX green staining was imaged by 488 nm and 405 nm for Hoechst staining 12 
nuclei. Total 17-22 fields of images were taken per wells. Then the percentage of cell death was 13 
quantified by the ratio between the number of Sytox green positive cells and the total number of Hoechst 14 
expressing cells per image using a Columbus StudioTM Cell Analysis Software.   15 
To visualise cytoplasmic membrane, cells were washed with HBSS and incubated with either CellMask 16 
deep red Plasma membrane Stain (TheroFisherScientific, 5たg/ml) for 5-10min or CellBriteTM Blue 17 
(Biotium, 5たM) for 30min in HBSS and live-cell imaging was performed. 18 
 19 
Measuring g-synuclein aggregate induced Ca2+ influx  20 
To characterise aggregation in neurons derived from SNCA x3, lysates and media were collected from 21 
both control and SNCA x3. Cells were lysed mechanically without using a lysis buffer. The lysates and 22 
media were collected in an Eppendorf tube and centrifuged at 15000 rpm for 15 min. Supernatant was 23 
collected in a fresh Eppendorf tube and kept in -80 until use.  24 
For the membrane permeabilization assay, vesicles are prepared as previously described (26). Using this 25 
assay, it has been previously shown g-synuclein oligomers disrupt and permeabilise membranes (27, 28). 26 
Briefly, vesicles are synthesized using Phospholipids 16:0-18:1 PC and biotinylated lipids 18:1-12:0 27 
Biotin PC (100:1) using freeze thaw method and mean diameter is 200 nm. Vesicles of oxidised lipid was 28 
made using oxPAPC (Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine) and 18:1-12:0 29 
Biotin PC. Each vesicle is filled with 100 たM Cal-520 dye and immobilised in PLL-g-PEG coated plasma 30 
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cleaned glass coverslips using biotin-neutravidin linkage. The surrounding of the vesicles was filled with 1 
Ca2+ buffer. 50 µL of sample was incubated with the vesicles for 15 minutes and Ca2+ influx was 2 
quantitatively measured using a homebuilt Total Internal Reflection Fluorescence Microscope (TIRFM) 3 
based on an inverted Nikon Ti-2 microscope.  488 nm laser was focused back-focal plane of the 100X, 4 
1.49NA oil immersion objective lens used to excite the Cal-520 dye. The fluorescence signal was 5 
collected by the same objective and magnified 1.5 times. Then the emission light was passed through a 6 
long pass filter (BLP01-488R-25) and a band pass filter (FF01-520/44-25) before imaged in EmCCD 7 
camera. To check if the aggregate present in SNCA x3 media and lysates are composed of g-synuclein, 8 
we have used previously reported method to determine the composition of the aggregates (29, 30). Media 9 
was incubated with Anti-Alpha-synuclein (phospho S129) antibody (Abcam ab51253), for 30 min and 10 
then added to the coverslips containing dye filled vesicles.  Statistical significance test was performed 11 
using two sample unpaired t-test. 12 
 13 
Electrophysiology 14 
Single-channel electrophysiology in living neurons 15 
Patch-clamp recordings of α-synuclein channels overexpressed in iPSC-derived neurons were performed 16 
in perfusion solution containing: 124 mM NaCl, 3 mM KCl, 1 mM CaCl2, 3 mM MgCl2, 26 mM 17 
NaHCO3, 1.25 mM NaH2PO4, 10 mM D-glucose, 2 mM CaCl2, 2mM MgCl2, bubbled with 95:5 O2/CO2 18 
(pH 7.4). To isolate response of α-synuclein channels we added to external solution 50 µM D-APV, 10 19 
µM NBQX, 100 µM picrotoxin and 1 µM strychnine. Outside-out patches were excised from cell soma 20 
with 5-6 MOhm borosilicate glass pipette and held at -70 mV membrane potential. Intrapipette solution 21 
contained 117.5 mM Cs-gluconate, 17.5 mM CsCl, 10 mM KOH-HEPES, 10 mM BAPTA, 8 mM NaCl, 22 
5 mM QX-314, 2 mM Mg-ATP, 0.3 mM GTP. As a control, we performed recordings from outside-out 23 
patches pulled from iPSC-derived neurons received from healthy volunteers. 24 
Recordings were performed at 33-35 ºC using Multiclamp-700B amplifier, in whole-cell mode; signals 25 
were digitized at 10 kHz. Recording electrodes were pulled from the thick-wall borosilicate glass 26 
capillaries and fire-polished to 5-7 MOhm resistance. 27 
In human stem cell derived neurons, to calculate and visualise amplitude characteristic for ion channel 28 
openings, we constructed all-points histograms with 0.1 pA bin, and fitted them with a double-Gaussian 29 
function: 30 
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where m1 and m2 are the mode values of Gaussians, σ1 and σ2 are the standard deviations of 2 
corresponding modes, n is the value of electrical current, and p1 and p2 are the fitting constants. 3 
With this approach the mode value for the open state was fitted as 2.17 pA. 4 
Channel activity in liposomes 5 
Giant liposomes were prepared as described previously (31). Briefly, liposomes were formed by 6 
sonication of lipid (type IV-S soybean L- -phosphatidylcholine; Sigma-Aldrich) in water. Liposomes (600 7 
µg lipid) were mixed with 5 mM Hepes, pH 7.4 (50 µl volume) and with protein sample (5 µl), and dotted 8 
on a glass slide. Samples were dehydrated (3 h) and rehydrated overnight with 150 mM KCl, 5 mM 9 
Hepes, pH 7.4, at 4 C. Patch-clamp procedures and analysis used were described previously (18). 10 
membrane patches were excised from liposomes after formation of a giga-seal using micropipettes with 11 
~0.4- m diameter tips and resistances of 1020 ΩM at room temperature. Voltage clamp was performed 12 
with the excised configuration of the patch-clamp technique using an Elements eONE patch clamp 13 
amplifier in the inside-out mode. Voltages are reported as pipette potentials. Current traces were 14 
processed using pCLAMP software. Traces for figure and all points histograms were prepared using 15 
Origin 9. 16 
 17 
ELISA assay 18 
To measure the concentration of oligomeric g-synuclein, cell lysates were mechanically from CTRL and 19 
SNCA x3 neurons.  g-synuclein oligomer was analysed using Human g-synuclein, alpha (non A4 20 
component of amyloid precursor) oligomer (SNCA oligomer) ELISA kit (CSB-E18033h, Generon) and 21 
then normalized by total protein per well using Pierce BCA Protein Assay Kit (23225, 22 
ThermoFisherScientific). 23 
 24 
Aptamer staining 25 
10 
 
Cells were permeabilized with 0.25 Triton X 100 and blocked with 10% Normal Goat Serum for 20 min 1 
followed by another 3 hrs with 0.1% Triton X -100 and 10% Normal Goat Serum. Then cells were 2 
incubated overnight with 0.5uM ATTO 425 labelled Aptamer (32). Cells were washed three times with 3 
PBS and imaged.  4 
 5 
Immunohistochemistry 6 
Cells (cultured in ibidi chamber) were fixed in 4% paraformaldehyde and permeabilized with 0.2% 7 
Triton-100. 5% BSA was used to block non-specific binding. Cells were incubated with primary antibody 8 
for 1hr at room temperature and washed three times with 5% BSA. Cells were incubated with secondary 9 
antibody (see SFigure 1 for antibody lists) for 1hr at room temperature. Cells were imaged with PBS after 10 
three times wash. Hoechst was added in the second wash if required.  11 
 12 
Statistical analysis 13 
Statistical analysis (unpaired two sample t-test or one-way ANOVA, P value is set at 0.05) and curve 14 
fitting were performed using Origin 2018 (Microcal Software Inc., Northampton, MA) software. Results 15 
are expressed as means ± standard error of the mean (S.E.M.). N = number of inductions and n= number 16 
of cells, if not stated otherwise. Sample sizes for experiments were selected to capture adequate technical 17 
variation (number of cells; numbers of fields of view; number of coverslips) and biological variation 18 
(numbers of independent inductions; numbers of clones/patient line). Variance within each group was 19 
estimated using a F-statistics (sum of squares). All experiments were repeated minimum three times. All 20 
experiments were performed in a count balance manner and data was collected and analysed without bias.   21 
 22 
Results 23 
Human iPS derived neurons with increased g-synuclein exhibit abnormal calcium signalling. 24 
Differentiation of control iPSCs (control, or CTRL), SNCA triplication iPSCs (SNCA x3), and isogenic 25 
control iPSCs, into cortical neurons was performed. The SNCA x3 mutation is a gene triplication, leading 26 
to a doubling of g-synuclein protein expression (20). We generated enriched populations of neurons from 27 
both control and SNCA x3 mutant lines, with a small proportion of glial-like cells (Figure 1 A, B).  28 
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Immunocytochemistry (g-synuclein Ab MJFR1, Abcam), demonstrated elevated g-synuclein protein 1 
expression in SNCA x3 cells (SFigure 2 Aa & b).  2 
We investigated whether physiological calcium responses are altered by increased expression of g-3 
synuclein. We stimulated iPSC-derived neurons with physiological concentrations of glutamate (5 µM) 4 
and KCl (50 mM) which induces opening of potential-sensitive Ca2+ channels that are specific for 5 
neurons. We then stimulated a calcium signal with 100 µM ATP which induces activation of P2Y 6 
receptors (33). There is no significant difference in the proportion of cells responding to either glutamate 7 
(neurons) or ATP stimuli (glia-like) in CTRL, SNCA x3 and Iso-CTRL (Figure 1 Ca & b). Stimulation of 8 
neurons with 5µM glutamate induces a significantly higher signal in SNCA x3 cells compared to both 9 
isogenic control and healthy control cells (CTRL: 0.65±0.04, n=96, SNCA x3: 1.2±0.1, n=99; p<0.001, 10 
Figure 1 Cc, Da & d). The physiological [Ca2+]c response to 50 mM KCl was also higher in SNCA x3 11 
iPSC-derived neurons (0.29±0.01, n=101) when compared to control neurons (1.01±0.039, n=114; 12 
p<0.001; Figure 1 Db & d). Stimulation with 100 µM ATP leads to an increase in [Ca2+]c in glial-like 13 
cells, but not in neurons. This [Ca2+]c response was significantly lower in glial-like cells with SNCA x3 14 
when compared to control cells (0.49±0.03, n=68 in CTRL; p<0.001; Figure 1 Dc & d). We also detected 15 
an impairment of intracellular calcium homeostasis in SNCA x3 showing re-distribution of Ca2+ stores, 16 
and depletion of ER calcium, and increase in mitochondrial calcium (SFigure 3).  17 
One of the major characteristics of mature neurons is their spontaneous calcium activity. Spontaneous 18 
calcium transients were observed in all iPSC-derived cortical neurons (Figure 1 Ea), with no significant 19 
difference in the amplitude of these transients (Figure 1 Eb) between CTRL and SNCA x3.  20 
 21 
Increased expression of g-synuclein in a hES model demonstrates altered calcium signalling. 22 
To test the effect specifically of SNCA expression in neurons, we utilized a model of transgenic human 23 
stem cell derived neurons engineered to express SNCA at control or high levels (18), on an isogenic 24 
background. Both control and SNCA o/e cells displayed a native-like membrane potential of 61±5mV 25 
(n=4), characteristic for neurons, and generated action potentials of classical shape in response to current 26 
injection. Action potentials in SNCA o/e cells were generated with significantly lower frequency: 4.2±1.3 27 
Hz vs. 18.7±3.4 Hz in control, P<0.01, n=4, 7, Students t-test. 1 µM of Tetrodotoxin (TTX) added into 28 
the perfusion solution fully suppressed action potential generation, revealing the presence of voltage-29 
gated sodium channels in the tested cells (SFigure 4 Aa & b).  30 
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To test the calcium response to physiological stimuli, we applied glutamate (10µM) which induces a 1 
typical calcium transient in control neurons, and SNCA o/e (SFigure 4 Ba & d, CTRL; n=47 cells, 2 
SNCAx3; n=32 cells). In agreement with previous results, glutamate-induced calcium signal in SNCA o/e 3 
was significantly higher than those found in CTRL (signal rose to 1.3±0.24 Fura-2 ratio compared to 4 
0.7±0.08 Fura-2 ratio, p<0.05). More than 60% cells demonstrated typical response to plasma membrane 5 
depolarisation with opening of voltage-gated calcium channels (SFigure 4 Bc & d). Again, SNCA o/e 6 
cells had significantly higher calcium responses to 50mM KCl (SFigure 4 Bc & d, CTRL; 0.92±0.1 Fura-7 
2 ratio, n=39, SNCAx3; compared to 0.61±0.08 Fura-2 ratio in control, n=38 cells; p<0.05).  8 
Application of 100µM ATP stimulates calcium signalling via P2Y receptors, expressed predominantly in 9 
astrocytes. Approximately 40% of cells in the field demonstrated a calcium response to application of 10 
ATP, and SNCA o/e cells demonstrated a higher ATP-induced calcium signal than control cells (SFigure 11 
4 Bb & d, CTRL; 1.21±2.2 Fura-2 ratio, n=37, SNCAx3; compared to control 0.97±0.07 Fura-2 ratio, 12 
n=47 cells; p<0.05). 13 
 14 
Alpha-synuclein aggregates disrupt membranes and alter membrane conductance.   15 
We investigated how g-synuclein aggregates disrupt membranes and induce ion fluxes. Using a 16 
ATTO425-labelled Aptamer that recognises aggregates of g-synuclein (32), we confirmed the increase in 17 
aggregates in the SNCA x3 cells, demonstrated both by intensity, and area of cell occupied by aggregates.  18 
(Figure 2 A). This aptamer, using super resolution microscopy (ADPAINT) has demonstrated an increase 19 
in larger aggregates in SNCA x3 neurons (32). We performed an oligomer ELISA to measure the soluble 20 
aggregates in the SNCA x3 and CTRL cell lysates (SFigure 5), and demonstrated a selective increase in 21 
oligomers in the SNCA x3 neurons (SFigure 5 B).  22 
Aggregates formed in the SNCA x3 cells, and secreted in the media, are capable of permeabilising 23 
membranes, and inducing ion fluxes. Using a single vesicle assay, we demonstrated that application of 24 
SNCAx3 lysates and media induced calcium influx across liposomes. This calcium influx was blocked 25 
after incubation of SNCAx3 lysates and media (25x dilution) with Anti- g-synuclein (phospho S129) 26 
antibody (see Figure 2 Ba for experimental paradigm). Therefore, both secreted oligomers in the 27 
extracellular space of SNCA x3, as well as internally generated oligomers possess a structural 28 
conformation that can interact with, and disrupt, membranes (Figure 2 Bb & c) to induce calcium fluxes.  29 
To test the effect of increased endogenous g-synuclein on the membrane conductance of neurons, we 30 
performed patch-clamp recordings from outside-out membrane patches in a voltage-clamp mode. To 31 
13 
 
isolate the response solely of channels formed by α-synuclein aggregates, we added to the external 1 
solution 50 µM D-APV, 10 µM NBQX, 100 µM picrotoxin and 1 µM strychnine. We registered single-2 
channel openings in patches excised from iPSC-derived neurons with SNCA x3 (channel conductance 3 
189±26 pS, n=5) while no single-channel activity was observed in control neuronal cultures when a 4 
similar cocktail of ion channel blockers was applied (Figure 2 Ca). However, we managed to detect 5 
activity only in a small fraction of SNCA x3 neurons (Figure 2 Ca); five successful recordings out of 29 6 
outside-out patches (each patch was pulled from a separate cell). To calculate the amplitude of the ion 7 
channel opening, all point histograms were constructed and fitted to a double Gaussian function. The 8 
mode value for the open state was fitted at 2.17 pA (Figure 2 Cb). This data suggests the presence of 9 
channel formation on the plasmalemmal membrane of neurons with high levels of g-synuclein, 10 
independent on any known ion channels. 11 
We investigated the effect of g-syn aggregates on the ion permeability of membranes, using patch-clamp 12 
of giant liposomes exposed to recombinant g-synuclein oligomers. We detected single channel activity 13 
induced by oligomers of g-syn, but not monomers (Figure 2 Da & b), and these channels had multiple 14 
conductance levels, with opening and partial inactivity to stable subconductance at a constant voltage, 15 
followed by higher conductance states induced at -20mV.  16 
 17 
Increased expression of g-synuclein leads to generation of reactive oxygen species and membrane 18 
oxidation. 19 
We have reported that oligomeric g-synuclein drives the aberrant generation of intracellular superoxide 20 
and hydrogen peroxide, and the depletion of antioxidants (17, 34). Basal superoxide production is 21 
increased in the SNCA x3 iPSC-derived neurons (17) and addition of recombinant oligomers further 22 
increased superoxide production (CTRL; 175 ± 11.9 %, N=4, p<0.0001, SNCA x3; 158.3 % to 343.0 ± 23 
37.3 %, N=4, p<0.0001, Figure 3 A). Consistently, hES cells with SNCA o/e also produce abnormal 24 
levels of superoxide (SFigure 6). SNCA x3 iPSC-derived neurons also exhibit an increase in basal lipid 25 
peroxidation from 0.161 ± 0.004 to 0.241 ± 0.007, both N=4, p<0.0001; addition of oligomers to control 26 
cells increased lipid peroxidation to 0.456 ± 0.003, N=4, p<0.0001; similarly, addition of oligomers to 27 
SNCA x3 increased lipid peroxidation to 0.408 ± 0.005, N=4, p<0.0001 (Figure 3 B).  28 
Isotopic reinforced polyunsaturated fatty acids (D-PUFAs) incorporate into lipid membranes and render 29 
them resistant to the ROS initiated chain reaction of lipid peroxidation. We pre-treated cells with 10 µM 30 
deuterated Linolenic acid (D4-Lnn), which prevented oligomer induced lipid peroxidation, and restored 31 
basal levels of lipid peroxidation in the SNCA x3 cells (Fig 3 B). Therefore, recombinant oligomers, as 32 
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well as oligomers generated in the SNCA x3 cells, induce oxidation of PUFAs, which can be modulated 1 
by the use of deuterated species.  2 
 3 
Lipid peroxidation influences the physical interaction of aggregates and membranes.  4 
g-synuclein- membrane interactions in cells are transient and difficult to capture. Membrane binding to 5 
the plasma membrane is a prerequisite prior to internalization of g-synuclein into the cell (35). Labelled 6 
oligomers (oligomers generated from AF488 monomeric g-synuclein) were applied to cells loaded with 7 
either a cell mask dye, or a membrane dye. Internalization of fluorescently labelled monomer and 8 
oligomer is demonstrated in figure 3 Ca and SFigure 7 Aa. Vitamin E is a tocopherol that inhibits lipid 9 
peroxidation by scavenging lipid peroxyl radicals. We pre-incubated cells with Trolox, a water soluble 10 
analogue of g-tocopherol which is able to incorporate into both water and lipid compartments, reduced 11 
the g-synuclein accumulation in the cell (as demonstrated by reduced AF488 area/cell, Figure 3 Cb and 12 
SFigure 7Ab.  13 
Next, we tested the effect of membrane oxidation on insertion of aggregates into membranes utilizing the 14 
membrane Permeabilization assay (described in Figure 2 Ca). Using vesicles generated from oxidized 15 
lipids, there is higher calcium influx on exposure to the same concentration of g-synuclein oligomers, 16 
compared to control lipid vesicle (Figure 3 D).  17 
Together, this data suggests that under conditions of membrane oxidation, there is an enhanced membrane 18 
binding of oligomers of g-synuclein, allowing ion fluxes across the membrane, as well as entry into the 19 
cell. This interaction is reduced in cells with non-oxidized membranes.  20 
 21 
Lipid peroxidation drives g-synuclein induced abnormal calcium signaling. 22 
Next we tested whether the g-synuclein induced calcium signaling is affected by lipid peroxidation. We 23 
demonstrated abnormal glutamate induced calcium signaling in SNCA x3 neurons (Figure 4Ab & Bb). 24 
Pre-incubation of cells for 24 hours with D4-Lnn restored the glutamate-induced calcium signaling back 25 
to control levels (from 2.50 ± 0.27, N=7, n=100, Figure 4 Ab & Da to 1.43 ± 0.25, n=7, N=7, p=0.0113, 26 
Figure 4 Ac & Da after the use of D4-Lnn). Pre-incubation of cells with D4-Lnn interestingly abolished 27 
the KCL-induced opening of voltage-dependent calcium channels (from 1.65 ± 0.22, N=9, n=114, Figure 28 
4 Ab & Db to 0.30 ± 0.09, N=5, n=165, p=0.0009, Figure 4 Ab & c, Db). ATP-induced calcium signal is 29 
significantly smaller in the SNCA x3 cells compared to control (CTRL: 1.92 ± 0.27, N=4, n=165, SNCA 30 
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x3: 0.75 ± 0.11, N=4, n=114, p=0.0062, Figure 4 Ba & c). This was also restored by the pre-incubation of 1 
D4-Lnn (1.70 ± 0.30, N=4, n=120, p=0.0251, Figure 4 Bc & Dc).   2 
We previously showed that dopamine induces calcium signaling through dopamine receptor independent 3 
mechanisms (36, 37), and this includes (i) the opening of voltage dependent calcium channels following 4 
dopamine uptake and depolarization of the plasmalemmal membrane and (ii) dopamine induced lipid 5 
peroxidation and activation of phospholipase C and release of calcium from ER stores. Application of two 6 
stimuli of dopamine induces a typical calcium response in control cells (37). However, SNCA x3 cells 7 
exhibited a significantly higher calcium response to the second stimulus of dopamine compared to control 8 
cells (SNCA x3: from 0.61 ± 0.09, n=160, N=8, n=160 to 1.89 ± 0.21, N=6, n=136, p=0.0001; Figure 4 9 
Ca & b). The calcium response to dopamine in SNCA x3 was fully abolished when cells were pre-treated 10 
with D4-Lnn (0.16 ± 0.08, N=4, n=148, p=0.0002; Figure 4 C & c, Dd). Complete prevention of the 11 
dopamine induced calcium response by D-PUFAs is likely to be due to blockade of both insertion of 12 
channels into the membranes (in keeping with depolarizing stimuli), as well as blockade of the PLC/IP3 13 
response. This data suggests that the incorporation of g-synuclein as a channel into the plasma membrane 14 
occurs when the PUFAs in membranes have undergone lipid peroxidation. Non-oxidisable PUFAs lead to 15 
membranes that are resistant to the insertion of oligomers and their channel-forming activity, and do not 16 
demonstrate glutamate/dopamine induced calcium deregulation. 17 
 18 
Oligomer-induced toxicity is dependent on iron and lipid peroxidation. 19 
SNCA x3 cells exhibit reduced cell viability compared to CTRL over time in culture, shown in Figure 5 20 
Aa-b. We tested the sensitivity to ferroptosis of our iPSC derived synucleinopathy model using the 21 
ferroptosis inducer, erastin, and we show that erastin induces a dose dependent increase in cell death, 22 
shown in Figure 5 B. Oligomer-induced oxidative stress is dependent on transition metal ions (17). We 23 
tested the effects of metal ion chelator (Desferoxamine, DFO), inhibitor of lipid peroxidation (D4-Lnn), 24 
and a ferroptosis inhibitor (Ferrostatin-1) on cell death in synucleinopathy (38). Application of oligomers 25 
but not monomers, induced cell death in control (Figure 5 Ca & b) neurons and SNCA x3 (Figure 5 Ca & 26 
c) neurons. Application of three different ferroptosis inhibitors, deuterated PUFAs, iron chelator 27 
desferrioxamine (DFO, Sigma), and ferrostatin-1 (Ferr-1, Sigma, Cat No. SML0583) each significantly 28 
reduced oligomer induced cell death back to basal levels in control cells (Figure 5 Ca & b) and in SNCA 29 
x3 cells (Figure 5 Ca & c). Taken together this data suggests that α-synuclein aggregates may induce 30 
ferroptosis, and that inhibitors of ferroptosis prevent α-synuclein-induced cell death, and inducers of 31 
ferroptosis exacerbate cell death. 32 
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 1 
Discussion 2 
Ferroptosis (39) describes a form of non-apoptotic regulated cell death occurring as a consequence of 3 
iron-dependent accumulation of lethal lipid peroxidation. Ferroptosis is characterized by cell swelling 4 
(oncosis), altered mitochondrial morphology (40), and unique features of lipid peroxidation with 5 
preferential oxidation of phosphatidylethanolamine (41). Suppression of the formation of oxidized lipids 6 
halts cell death. The downstream pathways whereby lipid peroxidation leads to cell dysfunction or death 7 
are not fully established, but are proposed to include loss of membrane integrity, opening of pores and 8 
loss of ionic homeostasis, formation of free radicals that inactivates membrane embedded proteins 9 
required for cell viability (42). The major criteria for determining ferroptosis are the ability to suppress 10 
death by iron chelators, lipophilic antioxidants, inhibition of lipid peroxidation, and depletion of lipid 11 
peroxidation. 12 
In neurodegeneration (43), a number of ferroptosis features are commonly reported, in particular 13 
depletion of glutathione, accumulation of lipid peroxidation products, excess extracellular glutamate, 14 
decreased cortical GPX4, increased lipoxygenase (LOX) activity, protection from lipophilic antioxidant 15 
vitamin E (in AD), protection from iron chelators (44), and protection from pioglitazone, an ACSL4 16 
inhibitor (45). Additionally, brain iron levels rise in during aging and neurodegenerative disease, which 17 
can be detected in living people (46) and in postmortem tissue.  However, lipid peroxidation and 18 
ferroptosis has not been previously investigated in synucleinopathy models of PD (47).  19 
Here we study the complex intersection between protein aggregation, calcium deregulation and lipid 20 
peroxidation. We have demonstrated that abnormal calcium fluxes, as well as abnormal intracellular 21 
stores, is an important biological property of specific g-synuclein oligomers, when applied exogenously to 22 
cell systems (13, 48). In this study, we demonstrate that increased endogenous levels of g-synuclein 23 
oligomers, are associated with high cytosolic calcium influx in response to activation of glutamate 24 
receptors or changes in plasmalemmal membrane potential. This could be attributable either to high 25 
expression of potential-sensitive calcium channels or increased activation of glutamate receptors. Our 26 
data suggests an increased presence of potential-sensitive channels on the plasmalemmal membrane of the 27 
human neurons with high levels of oligomeric g-synuclein. Such channels are known to be formed by the 28 
effect of g-synuclein beta-sheet rich oligomers on membranes (13). Notably, solution and solid-state 29 
NMR methods have confirmed that the exogenously applied oligomers used in this study, result in 30 
maximal membrane disruption by allowing the structured oligomer core to insert into the lipid bilayer and 31 
disrupt the integrity (14). In our study, oligomers induce ion fluxes in the absence of the NMDA receptor 32 
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components in artificial systems (liposomes), and additionally oligomers induce channel formation in the 1 
presence of NMDA blockade in outside out patches in cells, Taken together, this supports the hypothesis 2 
that the g-synuclein oligomeric species alone are able to insert into membranes (in particular oxidized 3 
membranes), upon depolarizing stimuli, leading to a voltage-dependent increase in cytosolic calcium 4 
influx in response to glutamate, KCl and dopamine.  5 
The second key feature is the ability for oligomeric g-synuclein, both when applied exogenously or when 6 
generated endogenously, to induce the production of superoxide and hydrogen peroxide (17) and lipid 7 
peroxidation (49). Notably, the mechanism of oligomer induced ROS production and lipid peroxidation is 8 
iron dependent, and non-enzymatic, likely dependent on the Fenton reaction (18) (17). As protein 9 
aggregates interact with, and disrupt, lipid membranes, we sought to modulate this interaction through 10 
altering membrane properties by their oxidation state (50). Lipidomics has previously been used to 11 
demonstrate that polyunsaturated fatty acids (PUFAs) are the most susceptible lipids in the course of 12 
ferroptosis (41), and that preventing peroxidation by supplementing cells with PUFAs deuterated at the 13 
susceptible bis-allcylic carbon suppresses ferroptosis (51). Based on this, supplementation of media with 14 
deuterated D4-linolenic acid has shown to prevent lipid peroxidation (49), and also to prevent ferroptosis 15 
(51). We show that supplementation of the media with deuterated PUFAs is able to prevent oligomer 16 
induced lipid peroxidation. We further demonstrated that in the absence of lipid peroxidation, the g-17 
synuclein-induced calcium dysregulation is also abolished, and physiological calcium signaling is 18 
restored. This effect is true for glutamate-induced, KCL-induced and also dopamine-induced calcium 19 
signaling which induces both a calcium influx (36), as well as generates ROS (37). We therefore 20 
confirmed that lipid peroxidation allows membranes to be more susceptible to aggregates inserting into 21 
them and disruption of ion fluxes. Stabilization of the oxidation state of the membrane prevents additional 22 
oligomeric channel insertion, and reduces ion fluxes across the membrane. Our hypothesis is that the 23 
oxidation state of the membrane confers its susceptibility to a physical and functional interaction with 24 
beta sheet rich oligomeric proteins. It is possible that oxidized lipids recruit more oligomers to the 25 
membrane, or that any individual rare oligomer event results in greater disruption of the membrane and 26 
more calcium influx, and it is challenging to distinguish these two possibilities (52). 27 
Iron chelators, d-PUFAs, and ferrostatin were all able to suppress cell death induced by toxic oligomeric 28 
g-synuclein, or by dopamine in neurons. Inhibition of toxicity using reduction of iron, suppression of lipid 29 
peroxidation, and ferrostatin meets the basic criteria set out for the definition of ferroptosis (53), and 30 
therefore we raise the hypothesis that g-synuclein may contribute to cell death by this pathway, while 31 
recognizing that other forms of apoptosis and necrosis also co-exist. The co-dependence of protein 32 
18 
 
aggregation, membrane damage and oxidative stress in ferroptosis in neurodegeneration may underlie 1 
why models based on a single factor alone (eg GPX4 deletion) do not exhibit neurodegeneration (54). 2 
Cellular aging, dopamine and g-synuclein oligomers place the cell in a state of aberrant ROS production 3 
and glutathione depletion, resulting in oxidative stress with lipid peroxidation. Oxidation of specific 4 
PUFAs, leads to the insertion of g-synuclein oligomers into the membrane forming channels that open in 5 
response to depolarization of the plasma membrane. This renders neurons vulnerable to physiological 6 
calcium signaling and exposes them to high levels of cytosolic calcium fluxes that may cause 7 
excitotoxicity and cell death. At least part of the g-synuclein aggregate-induced cell death is related to 8 
ferroptosis in which the iron dependent accumulation of lipid peroxidation plays an important role in the 9 
demise of neurons.  Whilst in cellular models, targeting lipid peroxidation specifically using deuterated 10 
PUFAs, is a useful tool to demonstrate the contribution of lipid oxidation to calcium fluxes, its direct 11 
application to patients may be hindered by the important physiological roles that lipid oxidation also plays 12 
in neuronal function. Nonetheless, modulation of lipid peroxidation or ferroptosis may represent new 13 
potential therapeutic approaches for Parkinsons disease.  14 
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1 
Figure 1. Abnormal calcium signalling in iPSC-derived neurons with SNCA x3. A) Protocol to 2 
differentiate iPSC to cortical neurons. B) The majority of cells are Tuj 1 (and not GFAP-positive) in both 3 
control (CTRL) and mutant (SNCAx3) lines, Ba) Representative images with Tuj 1 (neuronal market, 4 
red) and GFAP (astrocytic marker, green), DAPI (total cell number, blue). Bb) Percentage cell proportion 5 
expressing Tuj 1 or GFAP, N = 3 CTRL & SNCA. Ca) Representative tracers of cytosolic calcium rise in 6 
response to 5µM glutamate not to ATP. Cb) Percent cell population responding to either 5uM glutamate 7 
or 100uM ATP, N = 3 CTRL & SNCA. Cc) Application of 5µM glutamate induced a rise in cytosolic 8 
calcium, which was significantly higher in SNCA x3 neurons compared to control neurons, N = 3 CTRL 9 
& SNCA.  Da) 5uM glutamate induces calcium signaling. Db) Depolarization of cells with 50mM KCl 10 
results in opening of voltage dependent calcium channels and a cytosolic calcium signal, which was 11 
23 
 
significantly higher in SNCA x3 neurons compared to control. Dc) Stimulation of the P2Y receptors with 1 
100uM ATP induced a cytosolic calcium signal that was significantly lower in the SNCA x3 cells 2 
compared to control. Dd) Histogram demonstrates the mean values of the calcium signals induced by 3 
glutamate, KCl and ATP (Mean ± SEM), N = 3 per condition for CTRL & SNCA x3. Ea) Registered 4 
events of spiking activity in individual control and SNCA triplication cells (spikes are marked with 5 
arrows, orange-CTRL, teal-SNCA x3). Eb) No of events per cell*min*1000 (Mean ± SEM). n = 180 6 
CTRL and 125 SNCA x3 cells. *P<0.05, **P<0.001, ***P<0.0001.  7 
 8 
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Figure 2. g-synuclein aggregates disrupt membranes. A) iPSC derived cortical neurons from patients 1 
carrying 3x SNCA exhibit aggregates. Aa - c) Aptamer expression level (both area and intensity) is higher 2 
in iPSC derived neurons with SNCA x3, N = 3 CTRL & SNCA x3. Ba) Illustration of membrane 3 
permeabilization assay by measuring Ca2+ influx in vesicles. Bb & c) Cell lysates and media from 4 
SNCAx3 induce higher level of permeabilization than control, prevented by antibody (phospho S129) 5 
binding of g-synuclein aggregates, N = 3 CTRL & SNCA. Ca) Single-channel activity of g-synuclein in 6 
the membrane of iPSC-derived neurons. Top: control recording from outside-out patch pulled from 7 
control neurons. Middle: recording from outside-out patch pulled from SNCA x3 neurons. Bottom: 8 
extended section of the medium trace marked by the dashed lines. Vertical scale bar applying to all three 9 
traces; horizontal (time) scale bar apply to the top and medium trace. Cb) All-points amplitude histogram 10 
of channel openings in the membrane of iPSC-derived neurons with SNCA3x, fitted with double-11 
Gaussian function, N = 3 CTRL & SNCA. Da) Single-channel activity of g-synuclein in the membrane of 12 
giant liposomes consisting of lipids. Channels open followed by partial inactivation to a stable sub-13 
conductance level (open 1). After switch to  20 mV the channels open to a higher conductance state 14 
(open 2). Db) Current amplitude histogram of the g-synuclein channel activity in giant liposome patch 15 
represented in Ea. *P<0.05, **P<0.001, ***P<0.0001.   16 
  17 
25 
 
 1 
 2 
Figure 3. ROS production and lipid peroxidation induced by g-synuclein in neurons. A & B) SNCA 3 
3x neurons are vulnerable to exogenously applied g-synuclein oligomers A) Rate of ROS production in 4 
iPSC-derived SNCA x3 neurons is higher than in control neurons. (N = 3 CTRL, SNCA & D4-Lnn 5 
treated SNCA). Ba) Basal lipid peroxidation rate in iPSC-derived neurons with g-synuclein 3x is higher 6 
than the control neurons, but could be restored through pre-treatment with D4-Linolenic acid (D4-Lnn) in 7 
SNCA x3 neurons, which also prevented oligomer-induced lipid peroxidation (N = 3 CTRL, SNCA & 8 
D4-Lnn treated SNCA). Bb) Representative traces of Ba. C) Characterization of g-synuclein  membrane 9 
interactions. Ca) Representative images of exogenous oligomeric g-synuclein uptake (AF488 10 
fluorescence, green) into the cytoplasm (plasmic membranes are labelled with CellMaskTM Depp Red 11 
dye; magenta colour) in control neurons with or without Trolox treatment. Oligomer uptake was 12 
significantly reduced when membrane oxidation was inhibited by Trolox, N = 5 basal & Trolox. Cb) 13 
Trolox inhibits uptake of aggregate forms of g-synuclein. D) Calcium influx in the membrane 14 
permeabilisation assay was increased when vesicles composed of oxidised lipids were generated. 16:0  15 
20:4 PC non-oxidised membrane. Ox PAPC oxidised membrane, N = 3 non & oxidized membrane. 16 
*P<0.05, **P<0.001, ***P<0.0001.  17 
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Figure 4. Prevention of lipid peroxidation restores calcium dysregulation in SNCA 3x neurons. A) 1 
Representative traces showing deuterated PUFAs restore abnormal glutamate-induced calcium signaling 2 
or KCl-induced depolarisation in SNCA x3 neurons (Ab) to control levels (Ac). B) ATP induced calcium 3 
signal is smaller in the SNCA x3 cells (Bb) compared to control (Ba). This was also restored by pre-4 
incubation of the cells with D-PUFAs (Bc). C) Double bolus of dopamine (50µM) in SNCA x3 neurons 5 
evoked dysregulated calcium signal (Cb) in comparison to control response (Ca). Cc) Pre-incubation of 6 
the SNCA x3 cells with D4-Lnn prevents dopamine induced cytosolic calcium signals. D) Quantification 7 
histograms depicting the preventive effect of deuterated PUFAs (D4-Lnn) on the calcium response to 8 
application of glutamate (a, N = 4 CTRL, N = 5 SNCA, N = 7 D4-Lnn treated SNCA), KCl (b, N = 5 9 
CTRL, N = 7 SNCA, N = 4 D4-Lnn treated SNCA), ATP (c, N = 4 CTRL, SNCA & D4-Lnn treated 10 
SNCA) or dopamine (d, N = 5 CTRL, N = 3 & 4 SNCA, N = 3 D4-Lnn treated SNCA) in both control 11 
and iPSC-derived neurons with SNCA x3. *P<0.05, **P<0.001, ***P<0.0001.   12 
 13 
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1 
Figure 5. Increased cell death rate in SNCA x3 neurons is dependent on lipid peroxidation and on 2 
29 
 
the presence of iron. A) Cell viability of iPSC derived neurons over time in culture. Aa) Upon 1 
completion of neuronal maturation > day 60 (22), SNCAx3 cells show similar cell viability with CTRL. 2 
Neuronal loss of SNCA x3 is significantly increased over the following 20 days. Ab) Representative 3 
images of cell death. B) A dose response (0.01たM  10たM) effect of Erastin, a ferroptosis inducer, on 4 
toxicity in iPSC derived cortical neurons. 100uM Erastin data was excluded due to the high toxicity 5 
preventing accurate quantification of cell death (* P < 0.05 compared to untreated, # P < 0.05 compared 6 
to 0.01たM and + P < 0.05 compared to 0.1たM condition. *P<0.05, #P<0.05 compared to untreated, 7 
+P<0.05 compared to 0.01ȝM).  Ca) Representative images depicting g-synuclein-induced toxicity 8 
induced by 1たM ɲ-synuclein monomer (10nM oligomer) overnight and its rescue by blocking ferroptosis. 9 
D-PUFA (48hr), Ferrostatin (1hr) & DFO (1hr) were pre-incubated prior to oligomer treatment). Blue-10 
Hoechst 33342 (total number of cells); green-SYTOX green (dead cells). Cb & c) Comparison of the 11 
effects of transition metal ion chelator (DFO), inhibitor of lipid peroxidation (D4-Lnn), and Fer 12 
(ferrostatin-1) a ferroptosis inhibitor on cell death, induced by g-synuclein oligomers within control (B, N 13 
= 3 per condition) and SNCA triplication (C, N = 3 per condision). *P<0.05, **P<0.001, ***P<0.0001.  14 
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Figure 6. Schematic diagram illustrating mechanisms of g-synuclein induced ferroptosis. 2 
Oligomeric g-synuclein induces 1) ROS and 2) lipid peroxidation within the membrane which results in 3 
an increase in 3) oligomer  membrane interaction, and consequently causes 4) calcium influx. The 4 
consequence of those events leads to cell death, 5) Ferroptosis. 5 
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